Sirius Therapeutics Inc.

Venous Thromboembolism Prevention

Clinical research is centered on the prevention of venous thromboembolism, with attention to clot-related events in surgical settings and perioperative care.

  • Thromboembolic event prevention
  • Orthopedic surgery-associated risk
  • Postoperative anticoagulation

The sponsor’s trial activity in this area reflects interest in reducing deep vein thrombosis and pulmonary embolism in patients undergoing major joint procedures.

Orthopedic Surgery and Perioperative Care

Research focuses on patients undergoing total knee arthroplasty, where postoperative clot prevention is a key therapeutic concern.

  • Total knee arthroplasty
  • Elective joint replacement
  • Perioperative thromboprophylaxis

This area links surgical recovery with management of coagulation-related complications in orthopedic patients.

Anticoagulation and Hemostasis

The sponsor’s clinical interest includes anticoagulant therapy and the balance between clot prevention and bleeding safety.

  • Anticoagulant treatment
  • Bleeding risk assessment
  • Comparative thromboprophylaxis

Comparative evaluation against established agents highlights a focus on therapeutic options used to manage coagulation disorders in clinical practice.

Safety and Tolerability Assessment

Research activity also includes evaluation of safety outcomes in patients receiving treatment for clot prevention.

  • Treatment tolerability
  • Adverse event monitoring
  • Clinical safety profiling

This supports development work in thrombosis-related care where both efficacy and safety are clinically important.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

    Recruiting

    1 1
    Investigated drugs:
    Bulgaria Czechia Hungary Latvia Lithuania Poland